DermTech, Inc.

Constellation Alpha Capital Corp (Nasdaq: CNAC), sponsored by Constellation Alpha Capital Partners, was a healthcare and medtech-focused special purpose acquisition company that completed its IPO in 2018. The SPAC announced a business combination with DermTech, Inc., a La Jolla-based precision dermatology company that develops non-invasive genomic testing tools for the early detection of skin cancer, in May 2019. The transaction has since closed, bringing DermTech to the public markets under its own listing. For complete deal documentation, SEC filing history, and comparable healthcare SPAC transaction data, sign up for full access at SpacDesk.

SPAC Counterparty (1)